Eric J. Ende - 01 Aug 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Reporting relationship: Director
Issuer ticker: AVDL
Reported as of: 01 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Aug 2023, 16:19:00 UTC
Prior SEC filing: 19 May 2023
Next SEC filing: 03 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Jerad G. Seurer, as Attorney-in-Fact

Key filing fact

Eric J. Ende filed Form 4 for AVADEL PHARMACEUTICALS PLC (AVDL) on 03 Aug 2023.

Key facts

This page summarizes Eric J. Ende's Form 4 filing for AVADEL PHARMACEUTICALS PLC (AVDL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Aug 2023, 16:19.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVDL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +33,000
Change %
Price: $0.000000
Shares after: 33,000
Date: 01 Aug 2023
Ownership: Direct
Underlying class: ADSs
Underlying amount: 33,000
Exercise price: $14.10
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Options shall vest in full on the earlier to occur of (a) August 1, 2024 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time.

Footnote F2

The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.